Thomas Mavromoustakos), ankol@pharm.uoa.gr (Antonios Kolocouris) Highlights  The investigation and observations made for the M2TM, excess aminoadamantane ligands in DMPC were made using the simpler version of biophysical methods including SDC, SAXS and WAXS, MD simulations and ssNMR.  At low peptide concentrations of influenza A M2TM tetramer in DPMC bilayer, two lipid domains were observed that likely correspond to the M2TM boundary lipids and the bulk-like lipids. At high peptide concentrations, one domain was identified which constitute essentially all of the lipids which behave as boundary lipids. The influence of the M2TM on the DMPC bilayers without or with drug was evaluated by DSC and SAXS.  1 H, 31 P ssNMR and MD simulations, showed that M2TM in apo form or drug-bound form span the membrane interacting strongly with lipid acyl chain tails and the phosphate groups of the polar head surface. The MD simulations showed that the drugs anchor through their ammonium group with the lipid phosphate and occasionally with M2TM asparagine-44 carboxylate groups. The 13 C ssNMR experiments allow the inspection of excess drug molecules and the assessment of its impact on the lipid head-group region.  According to SAXS, WAXS, and DSC in the absence of M2TM both drugs exerted a similar perturbing effect on the bilayer at low concentrations, ie x=0.05-0.08. At the same concentrations of the drug when M2TM is present, the Amt and, to a lesser extent, AK13 caused a significant disordering of chain stacking. Strikingly in a previous study it has been observed that both Amt and AK13 perturb similarly the DMPC bilayers in DSC, by decreasing T m , broadening DMPC bilayers half-width, and increasing ΔΗ at low concentrations, ie when x=0.05.This effect is likely due to the preference of AK13 to locate in closer vicinity to M2TM compared to Amt as well as the stronger ionic interactions of Amt primary ammonium group with phosphate groups, compared with the secondary buried ammonium group in AK13.
Introduction
Biophysical experiments and MD simulations have been applied to explore the effects of drugs and their complexes with biologically relevant lipophilic protein receptors in lipid bilayers. 1 The homotetrameric influenza A M2 protein is one of the simplest protein ion channels under investigation with M2TM spanning the lipid bilayer and consisting the ion channel pore (Figure 1 ). M2TM monomer is a lipophilic peptide with most of its lipophilic amino acid side chains orienting towards the hydrophobic core of the lipid bilayers or between adjacent helices. [2] [3] [4] [5] [6] [7] [8] [9] Aminoadamantane (Aamt) ligands bind inside the M2TM pore and block proton conduction, thereby preventing a continuation of the viral life cycle and abrogating pathogenesis. [2] [3] [4] [5] [6] State-ofthe-art ssNMR, x-rays, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , MD simulations [8] [9] 12 and other biophysical studies [18] [19] have been performed to investigate M2 protein structure and its complexes with Amt, rimantadine (Rim) and other Aamt derivatives. Conformational motions of M2TM without or with Aamt drugs were identified using ssNMR [19] [20] [21] [22] [23] [24] and described using x-ray crystallography [16] [17] and provide the necessary plasticity that is needed for full biological function. 23 The effect of drugs 25 and the lipid environment on the conformation and function of M2 protein have been carefully studied. [20] [21] [22] 26 Among the lipid bilayers studied, it was found that DMPC is an optimal membrane bilayer for this system, compared to other glycerophospholipids. 7, [20] [21] [22] [25] [26] The reverse also has been investigated, focusing on understanding the effects of the M2 protein on membrane required for virus budding. These effects induce changes in the mobility and packing of the lipids and the curvature of the lipid bilayers. 19, [27] [28] In a previous work, the effects of the M2 WT channel blockers Amt and AK13 on DMPC bilayers (Figure 1 ) were compared using DSC, x-ray scattering, ssNMR spectroscopy, and MD simulations. 29 It was found that the two drugs localized in the polar head area of the DMPC bilayers, stabilized through hydrogen bonding with sn-2 carbonyls in their amine form, and phosphate oxygens in their ammonium form. Such localization of the drugs explain their strong perturbing effect evidenced by all biophysical methodologies applied, and may be involved in a step for their insertion into M2 protein pore and effecting its conformational plasticity. 29 Although two-dimensional ssNMR and x-ray crystallography had been applied for the M2TM-Amt 11 , and M2TM-Rim 15 complexes, and the full length M2-Rim complex 30 , in this work a combination of more easily accessible biophysical methods was adapted. In particular, DSC, SAXS/WAXS, and 1 H, 13 C, 31 P ssNMR and MD simulations were used to identify changes effected by M2TM tetramers without and with excess of Amt and its spiranic analogue AK13 on DMPC lipids at pH 8.0, in which M2TM forms tetramers 31 .
X-ray scattering
SAXS experiments were carried out at the Austrian SAXS beamline (Elettra Sincrotrone, Trieste, Italy) 39 . Two-dimensional Pilatus3 1M and Pilatus 100k detectors (Dectris Ltd, Baden, Switzerland) were used to collect SAXS and WAXS scattering pattern, respectively. For SAXS, the sample to detector distance was 1048 mm. The x-ray wavelength was 0.154 nm at a photon energy of 8 keV, covering a q-range between 0.095 nm -1 to 7.54 nm -1 , where q is the magnitude of the scattering vector defined by q = 4π/λ sin(θ/2), with λ the wavelength and 2θ the scattering angle. For WAXS, the angular range covered corresponded to a qregime between 11.7 nm -1 and 21.2 nm -1 . The angular scale of the SAXS and WAXS measured intensity was obtained using silver behenate (CH 3 (CH 2 ) 20 COOAg), with a d-spacing value of 5.838 nm, and pbromobenzoic acid as calibration standards, respectively. The 2D images were integrated to 1D scattering functions with Fit2D, 40 and analyzed with IGOR pro (Wavemetrics, Inc., Lake Oswego, OR) to calculate when possible the characteristic lattice distance. The samples were loaded in a glass capillary and inserted in a dedicated sample holder, which was thermostated with a water bath having a temperature stability of ±0.1 °C (Unistat CC, Huber, Offenburg, Germany). The static measurements were done at 20 °C and 30 °C, acquiring 4 frames of 30 s, with 2 s delay between each frame. The samples were equilibrated for a few minutes at each temperature before exposure. The bilayer model used and its applications were recently presented. [41] [42] 
ΜD Simulations
The MD simulations were conducted with Desmond. The M2TM tetramer in complex with Amt or AK13 and additional five molecules of the Aamt ligand, to resemble the ratio of the constituents used in the biophysical studies, were embedded in DMPC lipid bilayers. The Aamt ligand is in its ammonium form at pH 8.0. The DMPC lipids represent the optimal membrane mimetic system in this case 26, 43 , having been used for the structure determination in 2KQT for retaining the proper M2TM structure compared to other glycerophospholipids. The DMPC lipid bilayer extended 20 Å beyond the solutes in x,y axes, resulting in a system including 120 lipid molecules. The bilayer was solvated using 20 Å thick layer of TIP3P waters 44 for each leaflet. Na + and Clions were placed in the water phase to neutralize the systems and to represent the experimental salt concentration of 0.150 M NaCl. The total number of system's atoms reached ~50000. Membrane creation and system solvation were conducted with the "System Builder" utility of Desmond (Schrodinger, Cambridge, MA) [45] [46] . For modeling the interactions, MD simulations were performed with both OPLS 2005 force field [47] [48] [49] and Amber ff99SB 50 force field, applied using the Viparr module of Desmond. Calculation of long-range electrostatic interactions, was utilized by the particle mesh Ewald method [51] [52] , with a grid spacing of 0.8 Ǻ. Van der Waals and short-range electrostatic interactions were smoothly truncated at 9.0 Ǻ. A constant temperature was maintaned in all simulations using Nosé-Hoover thermostat, and the Martyna-Tobias-Klein method was employed to control the pressure 53 . Periodic boundary conditions were applied using a simulation box of 95×70×81 Ǻ 3 . Multistep RESPA integrator 54 was used to integrate the equations of motion with an inner time step of 2 fs for bonded interactions, and non-bonded interactions within a cut-off of 9 Ǻ; an outer time step of 6.0 fs was used for non-bonded interactions beyond the cut-off. The default protocol provided by Desmond was modified in order to perform the MD simulations. The equilibration protocol consists of a series of restrained minimizations and MD simulations designed to relax the system, while not deviating substantially from the initial coordinates. Initially, two rounds of steepest descent minimization with a maximum of 2000 steps and harmonic restraints of 50 kcal mol -1 Ǻ -2 were applied on all solute atoms, followed by 10000 steps of minimization without restraints. The first simulation was run for 200 ps at a temperature of 10 K in the NVT ensemble with solute heavy atoms restrained with a force constant of 50 kcal mol -1 Ǻ -2 . The temperature was then raised during a 200 ps MD simulation to 325 K in the NVT ensemble with the force constant retained. The temperature of 325 K was used in the MD simulations in order to ensure that the membrane state is above the melting temperature state of 297 K for DMPC lipids. 55 The heating was followed by equilibration runs. Three stages of NPT equilibration (1 atm) with restraints were performed, first with the heavy atoms of the system restrained for 1 ns and the second with solvent and lipid molecules restrained harmonically with a force constant of 10 kcal/mol/Ǻ 2 for 10 ns. In the third stage, the C α atoms of M2TM were harmonically restrained with a force constant of 2 kcal/mol/Ǻ 2 for 1 ns. The above-mentioned was followed by a 200 ns NPT simulation without restraints. Within this time, the total energy, system dimensions, and the RMSD reached a plateau, and the systems were considered equilibrated. For structural analyses, snapshots of the different systems were visualized with VMD 56 or Maestro. 57 Trajectories were analyzed with Maestro, Gromacs, [58] [59] and VMD. Measurements were done with Gromacs tools. For the calculation of hydrogen bonds, a cut-off angle of 30 degrees deviation from 180 o between the donor-hydrogen-acceptor atoms and a cut-off distance of 3.5 Å between the donor and acceptor atoms were applied. The definition of boundary and non-boundary lipids was realized by the application of an algorithm which use Voronoi cells around protein atoms for the partition of the system 60 .
Results and Discussion

DSC results
At the two concentrations of M2TM in fully hydrated DMPC at pH 8.0 used in this research, x=0.03 and x=0.06 corresponding to M2TM tetramer : lipids ratio 1:120 and 1:64 respectively, M2TM forms quantitatively tetramers. 26 The thermal effects of the M2TM tetramer at these concentrations and in presence of a six-molar excess of Amt or AK13 were studied. The calorimetric data for pure DMPC bilayers were in accordance with the previous literature data. 61 In particular, there was a main sharp peak centered at 23.43 °C, exhibiting a high-enthalpy transition, accompanied by a broad low-enthalpy pre-transition centered at 13.27 °C (Figure 2a ) which signals the onset of the ripple phase during heating 62 and is more sensitive to disruption than the main transition. A thermal scan of the binary system DMPC + M2TM (x=0.03) as it is shown in Figure 2b is lacking the pre-transition but is still composed of two distinct peaks. The first domain (domain I) is a very broad small endothermic event centered approximately at 23 °C ( Figure 2b , Table 1 ). The second major domain (domain II) contains also a broadened peak with T m =20.60 o C, about 3 o C lower from that observed by DMPC bilayers alone. The formation of the two domains was studied systematically with time and was found to be persistent although with some modifications in their intensities. It may be suggested that the low-T m domain (II) corresponds to bulk DMPC lipids with strongly cooperative phase transition, but destabilization of the gel phase through long range interactions. Domain I correspond to lipids bound to M2TM tetramers, which constitute essentially all of the lipids at high peptide density (x=0.06, Figure 2e ). Shifting and broadening of lipid phase transitions, as well as elimination of pre-transitions are commonly observed upon membrane-insertion of proteins, e.g. mellitin, defensins, and gramicidin S. 28, [63] [64] [65] . Adding Amt or AK13 (x=0.05) in the mixture of DMPC + M2TM (x=0.03) affected both domains (Figure 2 c,d). Compounds Amt and AK13 did not differ appreciably in their effects at this concentration, AK13 slightly more than Amt. Both molecules further decreased the T m and ΔΗ m for the two domains. Interestingly, the presence of either drug resulted in decreasing the breadth of domain II and shifted the T m of both domains to lower temperatures. The sample composition for Figures 2c and 2d corresponds to one equivalent M2TM tetramer + six equivalents Amt or AK13 with 120 DMPC lipid molecules. It has been previously shown that when the sample composition is one equivalent M2TM tetramer + four equivalents Amt, one equivalent of the drug binds inside the high affinity binding site of the M2TM tetramer pore; it has been suggested that the excess of the drug, being concentrated in the lipid headgroup area, may interact with the four superficial D44 carboxylate groups of M2TM in the inner leaflet, but with a 40-fold lower affinity than for the pore interior. 23, 66 .
In the denser binary mixture DMPC + M2TM (x=0.06), which corresponds to a sample composition including the M2TM tetramer in 64 DMPC lipids, a very broad peak was observed at T m =22.8 o C, being very close to that of the pure DMPC bilayers, but with ΔΗ m highly decreased and ΔΤ 1/2 highly increased ( Figure  2e ). The second domain disappeared indicating that the M2TM is distributed uniformly in the lipid bilayers, such that at this density all lipids behave as boundary lipids. Interestingly, the two drugs in this lipid bilayer containing high-density M2TM cause different effects. In the ternary mixture DMPC + M2TM (x=0.06) + Amt (x=0.08) the DSC scan still may include two domains (or alternatively reinstates the pretransition upshifted to ~15.2 o C) ( Figure 2f ). But if so, domain II is now almost absent or at least less prominent compared to the lower concentration sample M2TM (x=0.03) + Amt (x=0.05) ( Figure 2c ). In fact, when the Aamt ligand is AK13 the DSC scan resulted in only one domain (Figure 2g ), similar to the single domain I of DMPC + M2TM (x=0.06) (Figure 2e ), suggesting that the M2TM-AK13 complex and the excess AK13 constituents are uniformly distributed in the lipid bilayer. Thus, the sample including five equivalents AK13, one equivalent M2TM-AK13 complex and 64 lipids did not produce a second domain compared to Amt, but it affects significantly only domain I by increasing ΔΤ 1/2 and lowering ΔΗ cal . Amantadine, having a primary ammonium group, can interact through stronger hydrogen bonds with phosphate oxygens of the polar head region in the bilayer, compared to AK13, effecting more efficiently the formation of a second distinct domain II of bulk-like lipid. In contrast, with the more lipophilic AK13 the spiro junction with adamantane buries the secondary ammonium group and hinders hydrogen bonding interactions. Indeed, it has been previously showed using 500 ns MD simulations that, although AK13 was also mainly localized in the polar head region, it could move easily between the two leaflets of the bilayer 29 . Table 2 ). The presence of M2TM (x=0.03) at 15 o C caused fluidization of DMPC bilayers at pH 8.0 as became evident from the appearance of peaks attributed to the alkyl chains (0.5-1.7 ppm) in Figure 3 (left). Increasing the concentration of M2TM (x=0.06) caused further fluidization of DMPC bilayers at pH 8.0 as the alkyl chain region covered broader range (0.0-2.7 ppm) while a systematic shift of the peaks in the lower field was observed ( Table 2 ). The spectrum of the sample DMPC + M2TM (x=0.03) + Amt (x=0.05) or AK13 (x=0.05) (Figure 3 , right) was similar to that of DMPC + Amt (x=0.05) or AK13 (x=0.05) (data shown in ref. 26 ). Therefore, the drugs mask the effects of M2TM at 0.5-1.7 ppm in the NMR spectrum. Additionally, it has been reported that Aamt drugs bound to the M2TM pore reduce its conformational plasticity 68 which is in agreement with the observed limited protein's effect on DMPC fluidization. When Amt or AK13 (x=0.08) and M2TM (x=0.06) concentrations were used (Figure 3 right), the spectrum at pH 8.0 appeared similar to that of DMPC + M2TM (x=0.03) (Figure 3 left) , but the peaks intensities were increased, suggesting instead a higher fluidization of DMPC acyl chains in this case. 13 C CP/MAS NMR at gel phase: M2TM at concentration x=0.03 did not modify chemical shifts and intensities of DMPC bilayer peaks acquired at pH 8.0; but did by 0-0.4 ppm at lower fields for the higher concentration of x=0.06 (Figure 4 , upper traces). The methyl group of DMPC resonance at δ=14.4 ppm in the same sample increased in intensity through cross polarization. When Amt or AK13 was incorporated at concentration x=0.05 (Figure 4 , lower traces), peaks of DMPC at ca 14 ppm and 54 ppm, which are susceptible to cross polarization effects, showed modified intensities. At higher concentrations of x=0.08, drugs shifted the chemical shifts by 0.2 ppm, most often towards the lower field ( Table 3 ). The peaks from the drugs (see asterisks in Figure 4 ; Table 3 ) were already observed at the lower concentration of x=0.05 but were more eminent at the higher concentration of x=0.08. It has been observed that when a stoichiometric amount of Amt with M2TM tetramer is present, the spectrum resembled the lipid-only spectrum. 14 Thus, the peaks in the bottom traces of Figure 4 , are due to the excess of drug molecule not bound with M2TM distributed in the DMPC bilayers. These peaks of the drug showed chemical shift changes that ranged between 0.4 to 1.4 ppm compared to the solution resonances suggesting an interaction of the drug with the membrane system (Table 4 ). narrow peaks in the 31 P spectra between 0 and 10 ppm correspond to the phosphate groups of the buffer solution. It is evident that M2TM at x=0.03 caused a decrease in the difference in the components of the shielding tensor σ II −σ I value by ca 10 ppm (Table 5) . At the highest concentration of x = 0.06, the σ II −σ I value decreased further by 4 ppm. These results show that M2TM perturbs, as expected, the polar headgroup of the lipid bilayers as it spans the transmembrane region. According to 31 P NMR spectra, the ternary system DMPC + M2TM (x=0.03) + Amt (x=0.05) or AK13 (x=0.05) produced σ Ι -σ II values almost identical to those of DMPC + M2TM (x=0.03) at the gel phase indicating that Amt and AK13 at concentration x=0.05 do not perturb further the phosphate groups region in the presence of M2TM. This is consistent with results from our previous paper 29 showing that at these concentrations the drugs did not change σ II −σ I value compared to pure DMPC. Only when the concentration of the drug was x=0.08 in the DMPC + Aamt system did the σ Ι -σ II value increase by 4 ppm compared to the pure DMPC. 29 The ternary system DMPC + M2TM (x=0.06) + Amt (x=0.08) or AK13 (x=0.08) gives σ Ι -σ II values increased by ca 3 ppm compared to those of DMPC + M2TM (x=0.06) at the gel phase temperature of 15 ºC. Figure 6 (left). At x=0.03 M2TM have no observable effect on the DMPC bilayers spectrum, suggesting that the protein is embedded in the lipid bilayer and does not significantly affect its dynamics. At the higher concentration of x=0.06 the intensities of the peaks grow, and the resonances are shifted to the lower field ( Table 6 ). The preparations DMPC + M2TM (x=0.03) + Amt (x=0.05) or AK13 (x=0.05) and DMPC + M2TM (x=0.06)+ Amt (x=0.08) or AK13 (x=0.08) resemble those of DMPC + M2TM (x=0.03) and DMPC + M2TM (x=0.06) correspondingly. As discussed previously in these two preparations the Aamt drug is inserted in the M2TM pore and the excess of molecules is distributed mainly in the bilayers. The observance of peaks with identical linewidths as those reported in our previous publication 29 where drugs perturbed DMPC bilayers not containing M2TM is an indication that Aamt drugs insert into and affect the lipid bilayer (see asterisks in Figure 6 ; Table 7 ). (Table 8 ). These are identical effects as at 15 ºC. Amt and AK13 also caused in the gel phase temperature (Figure 7 , Table 8 ). Table 5 ). This is not surprising as also similar effects were observed in the 1 H and 13 C NMR spectra for the gel and liquid crystalline phase. At 20 °C a typical pattern of a bilayer was observed in DMPC + M2TM (x=0.03). Adding the drug molecules, the formation of a broad shoulder was observed. This scattering pattern is consistent with DSC results suggesting the presence of two lipid domains, a major one with free lipids or free lipids including drugs molecules and a minor domain with M2TM boundary lipids. In the SAXS patterns drug molecules did not modify the d-spacing of DMPC + M2TM (x=0.03) bilayers substantially (Table 9 ). However, in WAXS spectra Amt exerted a significant disordering of the chain packing, more so than AK13, as no peak was evident at this temperature. At 30 °C the same conclusions can be drawn, implying that Amt is acting more effectively in both mesomorphic states. The only difference is that, at liquid crystalline temperatures, Amt significantly expands the d-spacing of the lipid bilayers, i.e. to 69.16 Å at x=0.05 ( Table 9 ). The ordering of the bilayers (peak width) is unaffected by the change of temperature. For high drug concentrations, i.e. DMPC+ M2TM (x=0.06), x-ray scattering patterns in the absence or presence of Amt or AK13 (x=0.08) at 20 °C (A) and 30 °C (B), are shown in Figure 10 . It is evident from the spectra at 20 °C that the broad component observed with lower peptide concentrations is absent. These results are again in harmony with DSC results showing the presence of only one lipid domain. Interestingly, in WAXS experiments all three samples at 20 °C or at 30 °C showed a very similar d-spacing which is again in consistent with the DSC results showing one domain of lipids uniformly occupied by M2TM and the Aamt ligand (Table 9 ). At both temperature the peak width of Amt is larger than the others indicating the stronger activity for the side chain disorder. However, at 30 °C, in the liquid crystalline phase the SAXS sample DMPC + M2TM (x=0.06) + Amt (x=0.08) does not show any peaks i.e. the formation of unilamellar vesicles, indicating a drastic modification of the lamellar structure of the lipid bilayers. In contrast, DMPC + M2TM (x=0.06) and DMPC + M2TM (x=0.06) + AK13 (x=0.08) samples showed similar d-spacing results. This is again in agreement with DSC results in which at this concentration of the sample, Amt appears to cause the most significant effect. Highlighting further the discrepancy, as evidenced in ref. 29 using DMPC lipids with only Amt at the same concentration, more ordered bilayers were observed resulting in Bragg peaks in SAXS and WAXS experiments. In the present samples with one equivalent of M2TM tetramer, six equivalents of Amt drug and 120 or 60 lipid molecules, the excess of Aamt drug can form stronger ionic hydrogen bonding interactions through its ammonium group with lipid phosphate groups and M2TM D44 carboxylate groups close to the bilayer surface compared to AK13 as discussed in the DSC results sub-section. The activity of Amt is generally visible by comparing the WAXS peak data for all temperatures and concentrations (Tabel 9). Here the general trend is observable that higher drug concentrations (with the exception of Amt) cause increased side chain packing, which is evidenced by the smaller d-spacings and smaller peak widths in the WAXS regime. 
MD Simulations
The MD simulations of the M2TM-Aamt complex and five molecules of Aamt in 120 DMPC lipids, to resemble experimental samples, showed that Aamt drug molecules were wrapped through ionic interactions to the lipid phosphate groups of the polar headgroup area and occasionally interact with M2TM D44 carboxylate groups lying close to the phosphate groups. This interaction was more frequent for AK13 compared to Amt. For the 120 DMPC lipids system the area-per-lipid for the M2TM boundary lipid region was calculated correspondingly at ca 47 Å 2 ; the definition of the boundary lipids was based on the Voronoi cells being close to the protein atoms. 60 These values are significantly lower than the calculated area-perlipid for the bulk lipid domain being correspondingly at ca 63 Å 2 . The M2TM boundary lipids are constricted because of their more oriented structure around M2TM. The experimental value for DMPC is ca 60 Å 2 as determined by SAXS. 69 The measurement of the mean distance between unbound Aamt and the centroid of G34 showed that AK13 remain closer to the M2TM compared to Amt, with the distance being 15 Å compared to 25 Å. This preference of AK13 to remain closer to M2TM may have important consequences leaving Amt to perturb more efficiently the DMPC bilayer. This is consistent with the RDF plots describing the distribution of an Aamt molecule from the center of the bilayer showing the frequent contact of AK13 while Amt was found apart from the M2TM pore ( Figure S1 ). 
Conclusions
In the present study, the effect of Amt and AK13 to the DMPC bilayers containing the M2TM was studied. The comparative perturbation of Amt and AK13 to the DMPC bilayers has been previously investigated. 29 In both studies a combination of experimental biophysical methods, ie DSC, SAXS/WAXS, ssNMR, and MD simulations were applied. It has been observed that both Amt and AK13 perturb similarly the DMPC bilayers in DSC, by decreasing T m , broadening DMPC bilayers half-width, and increasing ΔΗ at low concentrations, ie when x=0.05. In addition, they abolished the pre-transition signifying a perturbing effect on the phosphate head-group or hydrocarbon chain tilts that prevents formation of the ripple phase. 1 H, 13 C and 31 P NMR experiments confirmed these results and provided additional molecular details, showing that the two molecules affect the glycerol backbone and the carbonyl region of the headgroup region in their amine form, or the phosphate groups in their ammonium form. M2TM in apo or Aamt-bound form span the membrane thickness and, according to 31 P ssNMR evidence, exerted strong interactions with phosphate groups of the polar head surface. In addition, the pre-transition seen in DSC is ablated by M2TM without drugs, indicating that, like the drugs, the high (x=0.06, 64 lipid molecules per tetramer -32 in each leaflet) and even the moderate (x=0.03, 120 lipid molecules per tetramer -60 in each leaflet) peptide densities also perturb the headgroups or hydrocarbon chain tilts. The results of this work showed that at low concentration of embedded M2TM protein (x=0.03) in the DMPC bilayers in the absence or present of the Aamt drug (x=0.05), the DSC scan revealed two domains, one of bound lipids around the apo form of the protein complex, and another of bulk-like domain. These findings were confirmed by SAXS experiments. This system became uniform when M2TM protein is increased in concentration in the bilayer (x=0.06). The presence of an excess of the drugs as regards to M2TM in the membrane system affected the DSC profiles, indicating a clear perturbation in the M2TM containing bilayers. According to SAXS experiments, Amt induced a significant chain stacking disordering, in contrast to AK13 which showed only milder effect. It is thus evident, that the membrane perturbing effects of these drugs are different in the system containing M2TM protein compared to the effects of these drugs alone. The changes in the shape of 1 H NMR ssNMR spectrum provide information about the fluidization of the bilayers and the changes in the chemical shifts of 13 C signals of the drug, which were clearly observed at concentration higher than x=0.05, suggested interactions of the drug with the bilayer system. The MD simulations showed that the excess drug molecules, not bound to the protein, anchored to the polar head region with their ammonium interacting with the lateral surfaces of M2TM and occasionally with its D44 carboxylate groups, the last interaction being more frequent for AK13. The stronger effect of Amt compared to the more lipophilic AK13 at low drug concentration, when M2TM is present, is likely due to the to the preference of AK13 to locate in closer vicinity to M2TM compared to Amt as well as the stronger ionic interactions of Amt primary ammonium group with phosphate groups, compared with the secondary buried ammonium group in AK13. (24) 
